Ploumaki I, Triantafyllou E, Koumprentziotis IA, Karampinos K, et al. Cyclin-Dependent Kinase 4/6 Inhibitors as Neoadjuvant Therapy of Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: What do we Know so Far? Clin Breast Cancer 2024 Jan 16:S1526-8209(24)00002.
PMID: 38320891